Background Male circumcision is a primary HIV-1 prevention intervention for men, but whether the procedure reduces the risk of syphilis among men and their female partners is uncertain. We aimed to assess whether male circumcision was associated with incident syphilis in men and in their female partners.
Introduction
Data from more than 40 studies, including three randomised controlled trials, have shown that male circumcision provides at least 60% protection against acquisition of HIV-1 for heterosexual men. [1] [2] [3] [4] The consistently high effi cacy noted in the three randomised clinical trials was the impetus for WHO-UNAIDS recommendations in 2007 that medical male circumcision be a priority strategy for prevention of HIV and should be implemented in settings with low prevalence of male circumcision and high prevalence of HIV. 5 Several observational studies also support a preventive role for male circumcision for other sexually transmitted infections (STIs), including human papillomavirus, herpes simplex virus type 2, Trichomonas vaginalis, chancroid, Mycoplasma genitalium, and genital ulcer disease in heterosexual men. [6] [7] [8] [9] [10] [11] [12] [13] Although a meta-analysis of randomised and observational studies concluded that there was no association between male circumcision and risk of HIV in women (summary relative risk 0·80, 95% CI 0·53-1·36, heterogeneity p=0·05), 14 a protective benefi t of male circumcision on STI transmission to female partners has been reported. Data from randomised trials have shown reduced risk of human papillomavirus, genital ulcers, herpes simplex virus type 2, bacterial vaginosis, and T vaginalis in women whose partners are circumcised, whereas other observational studies did not show an association with bacterial vaginosis, T vaginalis, and Chlamydia trachomatis. [15] [16] [17] [18] [19] [20] [21] The potential association between male circumcision and syphilis was fi rst described in the mid-1850s in a medical report of patients with syphilis and Neisseria gonorrhoeae in which a greater proportion of non-Jewish men had syphilis compared with Jewish men, who were presumed to be circumcised because of religious practices. 22 Several recent studies, including one meta-analysis, have suggested that circumcised heterosexual men are at reduced risk of syphilis. 9 However, few studies have assessed the relation between male circumcision and incident syphilis status in men with HIV, and no studies to date have investigated the eff ect of male circumcision in HIV-infected or HIVuninfected men on syphilis acquisition in women. A protective eff ect of male circumcision on the risk of incident syphilis for HIV-infected and HIV-uninfected men and women could have important public health implications. Syphilis can lead to irreversible neurological and cardiovascular damage and syphilis during pregnancy can cause numerous adverse pregnancy and birth outcomes. 23 Male circumcision is currently being implemented as a medical procedure in settings of sub-Saharan Africa with high HIV burden, 24 and in those settings syphilis prevalence is also often high. Evidence of additional benefi ts against syphilis could enhance present medical male circumcision programmes. We aimed to investigate the association between male circumcision and incidence of syphilis in a HIV-infected and HIV-uninfected African men and their female partners.
Methods

Study design and participants
In this large prospective cohort study, participants were members of Kenyan and Ugandan HIV serodiscordant heterosexual couples enrolled in a randomised safety and effi cacy clinical trial of pre-exposure prophylaxis (PrEP) for HIV-1 prevention (the Partners PrEP Study). 25, 26 Trial recruitment, eligibility and exclusion criteria, and followup procedures have been previously described. 25 All couples received a comprehensive package of HIV prevention services, including individual and couples riskreduction counselling, screening and treatment for STIs, condoms, and referral for medical male circumcision and post-exposure prophylaxis according to national policies. At enrolment into the trial, HIV-infected partners were not eligible for antiretroviral therapy (ART) under the national ART guidelines during the study; they were referred for initiation of ART when they became eligible.
At an interim review, the trial's independent data safety and monitoring board recommended that the placebo group be discontinued early because of clear demonstration of PrEP effi cacy for HIV prevention. 25 All participants were informed of the outcome and continued on active PrEP thereafter. Data through study completion (between 2008 and 2013) were included in this prospective analysis of male circumcision and incident syphilis.
The Partners PrEP Study protocol was approved by the University of Washington Human Subjects Review Committee and ethics review committees at all of the study sites. 25 All participants provided written informed consent in English or their local language.
Procedures
HIV-uninfected participants attended monthly and HIVinfected partners attended quarterly visits for up to 36 months. Follow-up visits included standardised interviews about sexual behaviour in the past 30 days, medical history, and assessment of clinical and laboratory safety. Male circumcision status was determined by physical examination at the time of study enrolment and every annual follow-up visit and reported as fully circumcised, partially circumcised, or not circumcised. HIV-uninfected partners underwent HIV testing and were dispensed study medication. For HIV-infected partners, CD4 cell counts were quantifi ed every 6 months with standard fl ow cytometry and plasma HIV-1 RNA levels were quantifi ed with the COBAS Ampliprep/ COBAS TaqMan real-time HIV-1 RNA assay (version 1.0; Roche Diagnostics, Indianapolis, IN, USA), with a lower limit of quantifi cation of 240 copies per mL.
Detailed descriptions of the Partners PrEP Study STI diagnostic testing are provided elsewhere. 26 Study participants with syphilis at enrolment were deemed to have a new incident infection during follow-up if the rapid plasma reagin titre increased by four-fold or more from the previous visit. For study participants with a negative rapid plasma reagin at enrolment, a positive rapid plasma reagin with a confi rmatory positive T pallidum haemagglutination assay at a follow-up visit was defi ned as an incident syphilis infection; and subsequent infections were deemed to be incident if a four-fold increase in rapid plasma reagin titre had occurred. Only incident nonpersistent syphilis infections detected through serological testing were included in the fi nal analysis.
Statistical analysis
All couples in whom the circumcision status of the male partner was available were included in the statistical analysis for this study; a small number of couples with partially circumcised men were excluded. χ² tests for proportions and Kruskal-Wallis tests for continuous measures were used to detect diff erences in demographic, behavioural, and medical characteristics between couples with circumcised versus un circumcised male partners at enrolment.
Diff erences in syphilis detected at enrolment in circumcised male partners versus uncircumcised male partners (or women with exposure to circumcised versus uncircumcised male partners) were assessed with multivariate logistic regression. To assess incident syphilis during follow-up, Andersen-Gill survival models were used to allow for multiple events per individual. Male circumcision status was analysed as a timedependent exposure variable, accounting for uncircumcised men who became circumcised during study follow-up. Separate analyses were done to compare syphilis incidence rates in HIV-infected and HIVuninfected men by their circumcision status and in HIVinfected and HIV-uninfected women by whether their male partner was circumcised or uncircumcised. Diff erences in the eff ect of male circumcision on syphilis incidence between HIV-infected and HIV-uninfected study participants were assessed with a likelihood ratio test of interaction within our adjusted Andersen-Gill survival models. HIV-uninfected participants at enrolment who became HIV-infected during study follow up were censored at seroconversion. HIV-infected participants were observed throughout study follow-up regardless of partners' seroconversion status.
We decided a priori to adjust our statistical models for age at enrolment, reported unprotected sex with the study partner in the past 30 days, and plasma HIV RNA concentration of the partner with HIV in the couple because of the known associations of these factors with male circumcision status or risk of STI or HIV transmission. [27] [28] [29] [30] Unprotected sex and HIV RNA concentration were analysed as time-dependent variables
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Circumcised male partner (n=1575) To examine the robustness of our Andersen-Gill models, we repeated the primary analysis with Poisson generalised estimating equation regression models for intervalcensored failure time data. 31 We also did sensitivity analyses by excluding cases with a subsequent four-fold titre increase in rapid plasma reagin after previously detected incident syphilis to reduce potential misclassifi cation due to treatment failure; by restricting the analysis to study participants whose partners had serological evidence of syphilis infection to examine the eff ect of male circumcision on syphilis infections with the clearest evidence of linkage within the study partnerships; and by restricting the analysis to men who became circumcised during follow-up to examine the eff ect of the period immediately following the medical male circumcision procedure on syphilis acquisition and transmission. Data were analysed with STATA 13.1/MP for Windows (Stata Corporation, College Station, TX, USA).
Role of the funding source
The funder had no involvement in the study design, data collection or analysis, interpretation of results, and writing of this report. The corresponding author had full access to all data in the study and had fi nal responsibility for the decision to submit for publication without involvement of the funding source.
Results
4716 couples (99% of couples in the clinical trial) met criteria for inclusion in this analysis, of whom the HIVinfected partner was female in 2946 couples and male in 1770 couples (table 1); 31 were excluded because of missing data or for having a "partial" male circumcision status. The median age at enrolment was 30 years (IQR 25-36) for women and 36 years (30-42) for men; most (98%) couples were married and had a median of two children (IQR 1-4) together. The median number of sex acts in the previous month was four table 1 ). Couples with circumcised men were more educated, more often from Kenya, had more children, reported unprotected sex with the study partner less frequently in the past month, had male partners that reported sex with an additional partner less frequently, had lower plasma HIV-1 RNA concentration of HIVinfected partners, and had a lower prevalence of curable STIs among female partners (table 1) .
Circumcised men with and without HIV had a lower prevalence of syphilis at enrolment than those who were uncircumcised (table 2). This same pattern was noted in women.
1645 men with HIV, 2744 men without HIV, 1643 women without HIV, and 2773 women with HIV had complete information about male partner circumcision status, at least one syphilis serology result, and sexual behaviour data during study follow-up and were included in the fi nal analysis of incident syphilis risk ( Data are N (%), unless otherwise stated. OR=odds ratio. *Adjusted model includes: age, plasma HIV-1 RNA (log 10 copies/mL) of HIV-infected partner, and reported recent unprotected sex with study partner. the study was 2·75 years (IQR 2·30-2·79). 221 incident syphilis infections were reported: 46 (21%) in men with HIV (incidence 1·10 per 100 person-years), 76 (34%) in men without HIV (1·09), 54 (24%) in women with HIV (0·77), and 45 (24%) in women without HIV (1·11). 21 individuals had more than one incident syphilis infection during follow-up (nine women and 12 men). Overall, male circumcision was associated with a 42% reduction in incident syphilis in men (table 3) , including a 62% reduction in men with HIV (aHR 0·38, 95% CI 0·18-0·81) and a non-signifi cant reduction in incident syphilis in men without HIV (0·64, 0·36-1·11). No signifi cant diff erence was noted between the eff ect of male circumcision on syphilis incidence between HIV-infected and HIV-uninfected men (likelihood ratio p interaction =0·26). Among women, circumcision of their male partners was associated with a 59% reduction in incident syphilis, including a 75% reduction among HIV-uninfected women (aHR 0·25, 95% CI 0·08-0·76) and a 48% reduction among HIV-infected women (0·52, 0·27-0·97). The eff ect of male circumcision on syphilis incidence between HIV-infected and HIVuninfected women was not signifi cantly diff erent (likelihood ratio p interaction =0·17). Analysis with Poisson generalised estimating equations regression models for interval-censored failure time data produced results that were very similar to all Andersen-Gill models (data not shown).
To reduce potential misclassifi cation of rapid plasma reagin titre increases representing syphilis treatment failure rather than new infections, we excluded cases with a subsequent four-fold titre increase in rapid plasma reagin after previously detected incident syphilis. Results were similar to those from the full cohort: for HIV-infected men, the adjusted HR was 0·43, 95% CI 0·19-0·99 (36 events) for HIV-uninfected men, the adjusted HR was 0·58, 95% CI 0·33-1·04 (47 events), for HIV-infected women, the adjusted HR was 0·56, 95% CI 0·29-1·06 (38 events) and for HIV-uninfected women, the adjusted HR was 0·28, 95% CI 0·10-0·84 (32 events). To reduce potential misclassifi cation of syphilis acquisition from outside partners, we restricted the cohort to study participants whose partners had serological evidence of syphilis infection. Results were of similar magnitude to those from the full cohort, although power was restricted: for HIV-infected men, the adjusted HR was 0·39, 95% CI 0·06-2·47 (nine events in 84 men), for HIV-uninfected men, the adjusted HR was 1·18, 95% CI 0·34-4·14 (19 events in 111 men), for HIV-infected women, the adjusted HR was 0·73, 95% CI 0·24-2·23 (15 events in 115 women), and for HIV-uninfected women, the adjusted HR was 0·85, 95% CI 0·09-8·32 (ten events in 103 women).
69 (4%) men with HIV and 132 (5%) men without HIV were circumcised during study follow-up and no incident syphilis infections were reported in their female partners. Two of 76 incident syphilis infections among HIVuninfected men and two of 46 incident syphilis infections among HIV-1 infected men were among men who became circumcised during follow-up; all four syphilis HR=hazard ratio. *Adjusted model includes age, plasma HIV-1 RNA (log 10 copies per mL) of HIV-infected partner, and reported recent unprotected sex with study partner. †Likelihood ratio test assessed diff erence in the eff ect of male circumcision on syphilis incidence between HIV infected and uninfected study participants. infections were detected at the same annual visit when men were fi rst documented to be circumcised. When we restricted our analysis to men who became circumcised during study follow-up, the results were qualitatively similar to those of the primary analysis.
Discussion
In this large prospective study from east Africa, male circumcision was associated with reduced prevalence and incidence of syphilis for men and women (panel). The magnitude of risk reduction associated with male circumcision ranged from 40% to 75% and was statistically signifi cant in all groups except for HIVuninfected men for whom a trend towards a protective benefi t was noted. Data assessing the relation between male circumcision and incident syphilis risk for HIVinfected men and female partners of men with and without HIV infection are few, and thus our fi ndings provide important new information about the medical benefi ts of male circumcision. There is a clear biological rationale for why male circumcision could protect against ulcerative STIs, such as syphilis. Uncircumcised men could be at increased risk because of penetration of pathogens through the inner surface of the foreskin and frenulum, or through microabrasions to the thinner epithelium lining the foreskin occurring during intercourse. 9 The warm, moist area under the foreskin could provide an environment that encourages replication of T pallidum and other pathogens. Male circumcision might reduce transmissibility to female partners by reducing the surface area of the glans where spirochete-containing ulcers can form. At the population level, male circumcision could benefi t women by reducing their risk of exposure to syphilis through reducing the risk of syphilis in their male partners. Present WHO guidelines recommend male circumcision programmes for HIV prevention among heterosexual men in settings with a high HIV/AIDS burden. 5, 14 The eff ect of male circumcision programmes in reducing syphilis incidence and secondary transmission, in addition to HIV incidence among heterosexual men, could potentially have important public health implications and warrants future investigation.
Several studies have examined associations between male circumcision and incidence of non-HIV STIs.
32 A meta-analysis of studies reporting on the association of male circumcision and syphilis, essentially among HIVuninfected men, reported a summary relative risk of 0·69 (95% CI 0·50-0·94) similar to our fi ndings. 9 Two previous randomised trials have assessed the eff ect of male circumcision (versus delayed male circumcision) on syphilis acquisition among HIV-uninfected men; neither found a protective eff ect: adjusted HR 1·10, 95% CI 0·75-1·65 and risk ratio 1·23, 95% CI 0·41-3·65. 8, 10 Both randomised trials excluded men who were HIV-infected or T pallidum-infected at baseline and reported low detection of syphilis at follow up. Our study did not have these exclusion requirements, and thus our participants could have had greater syphilis exposure, allowing observation of the eff ect of male circumcision on syphilis risk that was not possible in the recent clinical trials. This is the fi rst study to our knowledge that has reported a statistically signifi cant reduced risk of incident syphilis among female partners with circumcised male partners. Syphilis prevention in women continues to be an important goal. Several longitudinal studies and ongoing national-level surveys have established syphilis and HIV comorbidity among women in sub-Saharan Africa. 33, 34 Additionally, there are approximately 1 million new cases of congenital syphilis annually warranting further research on risk factors for syphilis among women and identifi cation and implementation of eff ective interventions. 35 Eff orts to promote medical male circumcision should emphasise the other reproductive health benefi ts to men and their female partners, including syphilis prevention, in addition to HIV prevention.
Limitations of our study included the annual assessment of male circumcision status, which reduced our ability to precisely determine when initially uncircumcised men became circumcised. We tested for syphilis annually and when clinically indicated but generally had restricted ability to detect all incident syphilis infections, especially infections that could have occurred between testing intervals, some of which were potentially treated by outside providers or indirectly treated with antibiotics prescribed for other medical conditions. Although our data are from couples, the 1-year interval between syphilis testing and absence of laboratory testing to link syphilis infections complicates
Panel: Research in context
Systematic review
We searched PubMed with the terms "male circumcision", "syphilis", "acquisition", "risk", and "female partners", for articles published between Jan 1, 1950, and June 30, 2014. Only articles available in English through original publication or translation were included. We identifi ed one meta-analysis synthesising studies between January, 1950, and April, 2004, that reported a signifi cant summary measure showing a protective eff ect of male circumcision on syphilis infection in men. 9 Two additional prospective studies published since this meta-analysis used randomised study designs to assess the relation between male circumcision and syphilis acquisition in HIV-1 uninfected men. 8, 10 These studies showed no diff erence in the rate of syphilis incidence in men without HIV who were randomised to immediate versus delayed medical male circumcision. We did not identify any studies that investigated the relation between male circumcision status and risk of syphilis in men with HIV or the relation between male circumcision status and risk of syphilis in female partners.
Interpretation
In this large prospective study, male circumcision protected against syphilis acquisition in HIV infected and uninfected men and women. If confi rmed by other studies, our results suggest that male circumcision could play an important part in syphilis control and could enhance the public health benefi ts of this eff ective intervention, particularly in settings with high HIV/AIDS comorbidity and where congenital syphilis persists as a public health problem. our ability to link syphilis infections within couples. Thus, some misclassifi cation could have occurred in assessment of male circumcision and incident syphilis if partners acquired syphilis from an outside partner whose male circumcision status was unknown. Results from our subanalyses restricted to study participants whose partners had previous evidence of syphilis infection were similar to those from our primary models although with limited power. Additionally, our study participants were mutually disclosed HIV-serodiscordant heterosexual African couples and therefore further data are needed to confi rm our results in other populations.
In conclusion, we identifi ed a consistent protective eff ect of male circumcision on syphilis incidence among HIV-infected and HIV-uninfected men and women. Our results add to the body of evidence that male circumcision prevents STIs in populations beyond HIV-uninfected men. If confi rmed, our results suggest that male circumcision could signifi cantly reduce syphilis incidence and related sequelae in both men and their female partners. A reduction in syphilis infection for men and women via male circumcision could have important implications for syphilis control and enhancing the public health benefi ts of this eff ective intervention, particularly in settings with high HIV/ AIDS comorbidity and where congenital syphilis persists as a public health problem.
